Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.

about

Levodopa-induced facial dystonia in a case of progressive supranuclear palsy.

P2860

Q39784103-34560FEF-0380-43A9-8778-F824AC44B18B

P2860

Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.

Item

http://www.wikidata.org/entity/Q44165271

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.

@en

Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.

@nl

type

Item

label

Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.

@en

Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.

@nl

prefLabel

Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.

@en

Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.

@nl

P1476

Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.

@en

P2093

Gi Yeong Choe

http://www.w3.org/2001/XMLSchema#string

Jong-Min Kim

http://www.w3.org/2001/XMLSchema#string

Ki Hyeong Lee

http://www.w3.org/2001/XMLSchema#string

Yoon-La Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease.

The rationale for the use of dopamine agonists in Parkinson's disease.

Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.

Progressive supranuclear palsy: postmortem chemical analysis.

A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia.

P304

1089-1090

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.10246

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Beom S Jeon

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12360566

http://www.w3.org/2001/XMLSchema#string

P921

levodopa

autopsy

dyskinesia

Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.

about

P2860

P2860

Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921